Your browser doesn't support javascript.
Is the new WHO definition of extensively drug-resistant tuberculosis easy to apply in practice?
Alagna, Riccardo; Cabibbe, Andrea Maurizio; Miotto, Paolo; Saluzzo, Francesca; Köser, Claudio Umberto; Niemann, Stefan; Gagneux, Sebastien; Rodrigues, Camilla; Rancoita, Paola Vittoria Maria; Cirillo, Daniela Maria.
  • Alagna R; IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Cabibbe AM; IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Miotto P; IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Saluzzo F; IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Köser CU; Dept of Genetics, University of Cambridge, Cambridge, UK.
  • Niemann S; Molecular and Experimental Mycobacteriology, Priority Area Infections, Research Center Borstel, Borstel, Germany.
  • Gagneux S; German Center for Infection Research (DZIF), Partner site Hamburg-Lübeck-Borstel-Riems, Germany.
  • Rodrigues C; Swiss Tropical and Public Health Institute, Basel, Switzerland.
  • Rancoita PVM; University of Basel, Basel, Switzerland.
  • Cirillo DM; Dept of Microbiology, P. D. Hinduja Hospital and Medical Research Centre, Mumbai, India.
Eur Respir J ; 58(1)2021 07.
Article in English | MEDLINE | ID: covidwho-1325339
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Tuberculosis, Multidrug-Resistant / Extensively Drug-Resistant Tuberculosis Type of study: Diagnostic study Limits: Humans Language: English Year: 2021 Document Type: Article Affiliation country: 13993003.00959-2021

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Tuberculosis, Multidrug-Resistant / Extensively Drug-Resistant Tuberculosis Type of study: Diagnostic study Limits: Humans Language: English Year: 2021 Document Type: Article Affiliation country: 13993003.00959-2021